These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28915803)

  • 61. HOXA10 promotes cell invasion and MMP-3 expression via TGFβ2-mediated activation of the p38 MAPK pathway in pancreatic cancer cells.
    Cui XP; Qin CK; Zhang ZH; Su ZX; Liu X; Wang SK; Tian XS
    Dig Dis Sci; 2014 Jul; 59(7):1442-51. PubMed ID: 24464212
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGFβ-signaling in hypoxic microenvironment.
    Nagpal N; Ahmad HM; Chameettachal S; Sundar D; Ghosh S; Kulshreshtha R
    Sci Rep; 2015 Apr; 5():9650. PubMed ID: 25867965
    [TBL] [Abstract][Full Text] [Related]  

  • 63. TGFβ2-mediated production of hyaluronan is important for the induction of epicardial cell differentiation and invasion.
    Craig EA; Austin AF; Vaillancourt RR; Barnett JV; Camenisch TD
    Exp Cell Res; 2010 Dec; 316(20):3397-405. PubMed ID: 20633555
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
    Afify A; Purnell P; Nguyen L
    Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-β1 signaling, enhancing human breast cancer cell migration and invasion.
    Miret N; Pontillo C; Ventura C; Carozzo A; Chiappini F; Kleiman de Pisarev D; Fernández N; Cocca C; Randi A
    Toxicology; 2016 Jul; 366-367():20-31. PubMed ID: 27519288
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells.
    Lin L; Hutzen B; Lee HF; Peng Z; Wang W; Zhao C; Lin HJ; Sun D; Li PK; Li C; Korkaya H; Wicha MS; Lin J
    PLoS One; 2013; 8(12):e82821. PubMed ID: 24376586
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Human breast cancer cell lines and tissues express tartrate-resistant acid phosphatase (TRAP).
    Adams LM; Warburton MJ; Hayman AR
    Cell Biol Int; 2007 Feb; 31(2):191-5. PubMed ID: 17088078
    [TBL] [Abstract][Full Text] [Related]  

  • 68. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
    Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H
    BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
    Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
    Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
    Liu F; Liu Y; Shen J; Zhang G; Han J
    Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation.
    Khan SA; Cook AC; Kappil M; Günthert U; Chambers AF; Tuck AB; Denhardt DT
    Clin Exp Metastasis; 2005; 22(8):663-73. PubMed ID: 16691370
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
    Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
    J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion.
    Bourguignon LY; Wong G; Earle CA; Xia W
    Cytoskeleton (Hoboken); 2011 Dec; 68(12):671-93. PubMed ID: 22031535
    [TBL] [Abstract][Full Text] [Related]  

  • 74. KYNU, a novel potential target that underpins CD44-promoted breast tumour cell invasion.
    Al-Mansoob M; Gupta I; Stefan Rusyniak R; Ouhtit A
    J Cell Mol Med; 2021 Mar; 25(5):2309-2314. PubMed ID: 33486887
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin.
    M Brandão-Costa R; Helal-Neto E; M Vieira A; Barcellos-de-Souza P; Morgado-Diaz J; Barja-Fidalgo C
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340328
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential inhibition of renal cancer cell invasion mediated by fibronectin, collagen IV and laminin.
    Brenner W; Gross S; Steinbach F; Horn S; Hohenfellner R; Thüroff JW
    Cancer Lett; 2000 Jul; 155(2):199-205. PubMed ID: 10822136
    [TBL] [Abstract][Full Text] [Related]  

  • 77. siRNA-mediated silencing of CD44 delivered by Jet Pei enhanced Doxorubicin chemo sensitivity and altered miRNA expression in human breast cancer cell line (MDA-MB468).
    Vahidian F; Safarzadeh E; Mohammadi A; Najjary S; Mansoori B; Majidi J; Babaloo Z; Aghanejad A; Shadbad MA; Mokhtarzadeh A; Baradaran B
    Mol Biol Rep; 2020 Dec; 47(12):9541-9551. PubMed ID: 33206362
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Selective regain of egfr gene copies in CD44+/CD24-/low breast cancer cellular model MDA-MB-468.
    Agelopoulos K; Greve B; Schmidt H; Pospisil H; Kurtz S; Bartkowiak K; Andreas A; Wieczorek M; Korsching E; Buerger H; Brandt B
    BMC Cancer; 2010 Mar; 10():78. PubMed ID: 20199686
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Terrein inhibits migration of human breast cancer cells via inhibition of the Rho and Rac signaling pathways.
    Kasorn A; Loison F; Kangsamaksin T; Jongrungruangchok S; Ponglikitmongkol M
    Oncol Rep; 2018 Mar; 39(3):1378-1386. PubMed ID: 29328460
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.
    Sharaf H; Matou-Nasri S; Wang Q; Rabhan Z; Al-Eidi H; Al Abdulrahman A; Ahmed N
    Biochim Biophys Acta; 2015 Mar; 1852(3):429-41. PubMed ID: 25514746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.